Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Abb Vie Inc. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $92 Billion
- Q2 2025
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Abb Vie Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 4,722,893 shares of ABBV stock, worth $1.03 Billion. This represents 0.95% of its overall portfolio holdings.
Number of Shares
4,722,893
Previous 1,753,691
169.31%
Holding current value
$1.03 Billion
Previous $367 Million
138.59%
% of portfolio
0.95%
Previous 0.44%
Shares
36 transactions
Others Institutions Holding ABBV
# of Institutions
4,382Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$38.7 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$17.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$11.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.09 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $386B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...